A Promising New Treatment for Allergic Disorders

Topical Zafirlukast

AdobeStock_315672497.jpeg

Accolade is a development-stage specialty biopharmaceutical company focused on developing a range of products to treat atopic and inflammatory allergic conditions. Our team is dedicated to re-purposing zafirlukast, a known Leukotriene Receptor Antagonist (LTRA) approved and marketed worldwide as Accolate®.